Author

F. Maestú

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Resting-state functional and spectral alterations underlying cognitive decline in biomarker-confirmed Alzheimer's disease: A systematic review.

Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with synaptic and large-scale network dysfunction. Resting-state alterations may provide functional correlates of AD pathology, but associations among intrinsic brain activity, biomarkers, and domain-specific cognition have not been s...

Soraya Alfonsín, Brenda Chino, J. de Frutos-Lucas et al. · NeuroImage: Clinical · 0 citations

Review Open access Aug 2026

Genetic associations with EEG signatures in mild cognitive impairment: insights into Alzheimer's disease pathophysiology

The mild cognitive impairment (MCI) continuum represents a critical stage in the Alzheimer's disease (AD), yet much of the genetic determinants underlying early neural dysfunction in AD remain unclear. Electroencephalography (EEG)-derived features as heritable markers of neuronal network activity may provide biological...

A. Siitonen, T. Saarinen, M. Liljestrom et al. · medRxiv · 0 citations

Open access Aug 2026

Cognitive components derived from traditional neuropsychological tests and their associations with plasma p-tau217 and p-tau181 in mild cognitive impairment: a multisite analysis.

BACKGROUND Currently, no single biomarker can reliably identify preclinical Alzheimer's disease (AD), particularly at or before the mild cognitive impairment (MCI) stage. Given the heterogeneity of MCI, integrative approaches are needed to improve early risk stratification. OBJECTIVES (i) To derive robust latent cogn...

Ana S. Perez, Hugo L. Hammer, V. Andersson et al. · GeroScience · 0 citations